TG Therapeutics Inc (TGTX)

Health Care > Major Pharmaceuticals

Price

  • Last Close
  • $ 31.88
    -0.9
  • Trading Volume
  • 793,600
  • Market Cap
  • $ 2.7B
  • 52-Week High/Low
  • 54.9 - $21.78

Earnings

  • Earning
  • 2020 2021
    $ -2.42 -
  • 2021 P/E Ratio
  • Trailing Forward
    -13.55 -
  • Short share
  • Date Shares Ratio
    Sep 30, 2019 13132736 16.04

Gain

  • 30-day
  • TGTX 6.78%
    S&P 500 4.06%
  • 90-day
  • -14.84%
  • 3.87%
  • 180-day
  • -22.71%
  • 8.42%
  • 52-Week
  • 14.82%
  • 31.69%

Dividend

  • Dividend
  • 0
  • Dividend Yield
  • ;0%
  • Outstanding
  • 81,874,896
  • 50 Day Avg Volume
  • 23615143

Calender

  • Fiscal Year End
  • Dec 31
  • Last Earning Date
  • Mar 02, 2021
  • Ex-Dividend Date
  • -
  • Current Year Beta
  • 1.18

Ratio

  • Debt To EQuity
  • 0
  • Return On Equity
  • -721.76%
  • Book Value
  • $4.5

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Q1 -0.7 -0.5 -0.4 -0.6 0.5 0.2 0.3 -0.3 -0.2 -2 84.3 -56.2
Q2 -0.6 -0.5 -0.4 -0.6 0.5 0.3 0.4 -0.4 -0.3 -0.2 -0.2 43.3
Q3 0 -0.7 -0.7 -0.4 0.5 0.5 0.3 -0.5 -0.2 -0.2 -0 1.1
Q4 0 -0.7 -0.4 -0.7 0.5 0.5 0.4 -0.5 -0.2 1 -84.6 28.7
A -1.3 -2.4 -2 -2.3 1.9 1.5 1.3 -1.6 -0.8 -1.4 -0.4 16.9

Dividend
+

Q1
Q2
Q3
Q4
A

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 -7.2% -12.2% 96.1% 73.2% 150.5% -28.6% -2.3% 76.9% 48.4% - -
Q2 -19.6% 98% -0.3% -4.4% -13.7% -28.9% 7.2% 36.1% 13.1% -7.4% -
Q3 -12.3% 37.4% -34.9% -58.4% 17.9% 27.7% -39.2% 13.6% -24% -64% -
Q4 -6.3% 94.4% 101.3% -25.6% -31.7% -39.9% 18.4% 48.5% -22.6% 61.8% -

Returns +
M

J F M A M J J A S O N D
2021 -7.2% -8.4% 9.2% -7.4% -22.4% 11.8% -9.3% -23% 25.7% -2.1% - -
2020 25.1% -18.7% -13.7% 19.5% 58.6% 4.5% 0.5% 26.7% 7.9% -3.9% 14.1% 77.3%

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
TGTX -39%364%173%-50%76%-61%-25%306%7%0%0%

Annual
Returns

52 Week
High/Low

Earnings

Chart